IFNG and melanoma: We engineered lipopolysaccharide (LPS) and interferon-γ (IFNγ)-matured, type-1-skewing DCs to express three melanoma tumor antigens (tyrosinase, MART-1 and MAGE-A6) through replication-defective adenovirus (AdV) transduction (9–11).